PRGF application following rotator cuff repair does not improve clinical outcome .
This report has been verified
by one or more authors of the
original publication.
Plasma rich in growth factors in arthroscopic rotator cuff repair: a randomized, double-blind, controlled clinical trial
Arthroscopy. 2013 Jan;29(1):2-9. doi: 10.1016/j.arthro.2012.08.01469 patients were randomized to evaluate the effectiveness of plasma rich in growth factors (PRGF) following arthroscopic repair of full-thickness rotator cuff tears. Patients received conventional surgery either with or with the application of PRGF after the arthroscopic procedure. The results at one year follow-up indicated that the administration of PRGF did not improve clinical outcome and tendon healing compared to conventional surgery without PRGF.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
